- Home
- Publications
- Publication Search
- Publication Details
Title
The Past, Present, and Future of Non-Viral CAR T Cells
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-06-09
DOI
10.3389/fimmu.2022.867013
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CAR T cells produced in vivo to treat cardiac injury
- (2022) Joel G. Rurik et al. SCIENCE
- Rapid manufacturing of non-activated potent CAR T cells
- (2022) Saba Ghassemi et al. Nature Biomedical Engineering
- Insight into next-generation CAR therapeutics: designing CAR T cells to improve clinical outcomes
- (2021) Emiliano Roselli et al. JOURNAL OF CLINICAL INVESTIGATION
- Nanomaterials for T-cell cancer immunotherapy
- (2021) Ningqiang Gong et al. Nature Nanotechnology
- Prognostic Impact of Corticosteroids on Efficacy of Chimeric Antigen Receptor T-cell Therapy in Large B-cell Lymphoma
- (2021) Paolo Strati et al. BLOOD
- Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
- (2021) Nikhil C. Munshi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Investigation of product derived lymphoma following infusion of piggyBac modified CD19 chimeric antigen receptor T-cells
- (2021) Kenneth Paul Micklethwaite et al. BLOOD
- CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells prepared by virus-free Sleeping Beauty gene transfer to treat multiple myeloma
- (2021) Sabrina Prommersberger et al. GENE THERAPY
- Contemporary Transposon Tools: A Review and Guide through Mechanisms and Applications of Sleeping Beauty, piggyBac and Tol2 for Genome Engineering
- (2021) Nicolás Sandoval-Villegas et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A nonviral, nonintegrating DNA nanovector platform for the safe, rapid, and persistent manufacture of recombinant T cells
- (2021) Matthias Bozza et al. Science Advances
- A global database of COVID-19 vaccinations
- (2021) Edouard Mathieu et al. Nature Human Behaviour
- BACH2 is a putative T cell lymphoma tumor suppressor that may play a role in product-derived CAR-T cell lymphomas
- (2021) Jay Daniels et al. BLOOD
- Inhibition of MEK pathway enhances the antitumor efficacy of chimeric antigen receptor T cells against neuroblastoma
- (2021) Akimasa Tomida et al. CANCER SCIENCE
- Phase I clinical trial of EGFR-specific CAR-T cells generated by the piggyBac transposon system in advanced relapsed/refractory non-small cell lung cancer patients
- (2021) Yajun Zhang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The tangled history of mRNA vaccines
- (2021) Elie Dolgin NATURE
- Cognate restriction of transposition by piggyBac-like proteins
- (2021) Thomas M Beckermann et al. NUCLEIC ACIDS RESEARCH
- Autologous antigen-presenting cells efficiently expand piggyBac transposon CAR-T cells with predominant memory phenotype
- (2021) Kayoko Nakamura et al. Molecular Therapy-Methods & Clinical Development
- Enzymatically produced piggyBac transposon vectors for efficient non-viral manufacturing of CD19-specific CAR T cells.
- (2021) Iva Kaštánková et al. Molecular Therapy-Methods & Clinical Development
- Comparison of 2-year outcomes with CAR T cells (ZUMA-1) versus salvage chemotherapy in refractory large B-cell lymphoma
- (2021) Sattva S. Neelapu et al. Blood Advances
- CAR T-Cell Therapy in Hematologic Malignancies: Clinical Role, Toxicity, and Unanswered Questions
- (2021) Saar Gill et al. American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting
- Combining the Expression of CD33.CAR and CXCR4 to Increase CAR-CIK Cell Homing to Bone Marrow Niche and Leukemic Stem Cell Eradication in Acute Myeloid Leukemia
- (2021) Marta Biondi et al. BLOOD
- Non-Viral Sleeping Beauty Transposon Engineered CD19-CAR-NK Cells Show a Safe Genomic Integration Profile and High Antileukemic Efficiency
- (2021) Tobias Bexte et al. BLOOD
- Phase 1/1b Safety Study of Prgn-3006 Ultracar-T in Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
- (2021) David A. Sallman et al. BLOOD
- Anti-CD117 CAR T Cells Incorporating a Safety Switch Eradicate Acute Myeloid Leukemia and Deplete Human Hematopoietic Stem Cells
- (2021) Chiara F Magnani et al. BLOOD
- Preclinical Evaluation of Prgn-3007, a Non-Viral, Multigenic, Autologous ROR1 Ultracar-T ® Therapy with Novel Mechanism of Intrinsic PD-1 Blockade for Treatment of Hematological and Solid Cancers
- (2021) Tim Chan et al. BLOOD
- Donor-Derived CAR T Cells Engineered with Sleeping Beauty in Pediatric and Adult Patients with Acute Lymphoblastic Leukemia Relapsed Post-HSCT
- (2021) Chiara F Magnani et al. BLOOD
- Clinical Trials of BCMA-Targeted CAR-T Cells Utilizing a Novel Non-Viral Transposon System
- (2021) Caitlin Costello et al. BLOOD
- A Phase I Study of CD19 Chimeric Antigen Receptor-T Cells Generated By the PiggyBac Transposon Vector for Acute Lymphoblastic Leukemia
- (2021) Nobuhiro Nishio et al. BLOOD
- Transposon-mediated generation of CAR-T cells shows efficient anti B-cell leukemia response after ex vivo expansion
- (2020) Leonardo Chicaybam et al. GENE THERAPY
- Correction: Genomic Analysis of Sleeping Beauty Transposon Integration in Human Somatic Cells
- (2020) Giandomenico Turchiano et al. PLoS One
- CRISPR-engineered T cells in patients with refractory cancer
- (2020) Edward A. Stadtmauer et al. SCIENCE
- RNA-guided retargeting of Sleeping Beauty transposition in human cells
- (2020) Adrian Kovač et al. eLife
- Codon Optimization: A Mathematical Programming Approach
- (2020) Alper Şen et al. BIOINFORMATICS
- Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium
- (2020) Loretta J. Nastoupil et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting CD33 in chemoresistant AML patient-derived xenografts by CAR-CIK cells engineered with an optimized Sleeping Beauty transposon version
- (2020) Maria Caterina Rotiroti et al. MOLECULAR THERAPY
- Direct delivery of piggyBac CD19 CAR T cells has potent anti-tumor activity against ALL cells in CNS in a xenograft mouse model
- (2020) Kuniaki Tanaka et al. Molecular Therapy-Oncolytics
- Biomaterials in Chimeric Antigen Receptor T-Cell Process Development
- (2020) Ian I. Cardle et al. ACCOUNTS OF CHEMICAL RESEARCH
- Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults
- (2020) Mark J. Mulligan et al. NATURE
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structural basis of seamless excision and specific targeting by piggyBac transposase
- (2020) Qiujia Chen et al. Nature Communications
- CAR T Cell Generation by piggyBac Transposition from Linear Doggybone DNA Vectors Requires Transposon DNA-Flanking Regions
- (2020) David C. Bishop et al. Molecular Therapy-Methods & Clinical Development
- Latest Advances for the Sleeping Beauty Transposon System: 23 Years of Insomnia but Prettier than Ever
- (2020) Maximilian Amberger et al. BIOESSAYS
- In Vitro-Transcribed mRNA Chimeric Antigen Receptor T Cell (IVT mRNA CAR T) Therapy in Hematologic and Solid Tumor Management: A Preclinical Update
- (2020) Thangavelu Soundara Rajan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Sleeping Beauty–engineered CAR T cells achieve antileukemic activity without severe toxicities
- (2020) Chiara F. Magnani et al. JOURNAL OF CLINICAL INVESTIGATION
- Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
- (2020) Jeremy S Abramson et al. LANCET
- TCR Redirected T Cells for Cancer Treatment: Achievements, Hurdles, and Goals
- (2020) Francesco Manfredi et al. Frontiers in Immunology
- Use of a Hybrid Adeno-Associated Viral Vector Transposon System to Deliver the Insulin Gene to Diabetic NOD Mice
- (2020) Que T. La et al. Cells
- In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo
- (2020) N. N. Parayath et al. Nature Communications
- Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
- (2019) Piotr S. Kowalski et al. MOLECULAR THERAPY
- Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
- (2019) Noopur Raje et al. NEW ENGLAND JOURNAL OF MEDICINE
- Novel AAV-mediated gene delivery system corrects CFTR function in pigs
- (2019) Ashley L. Cooney et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Therapeutic mRNA delivery to leukocytes
- (2019) Yasmin Granot-Matok et al. JOURNAL OF CONTROLLED RELEASE
- Transposon-encoded CRISPR–Cas systems direct RNA-guided DNA integration
- (2019) Sanne E. Klompe et al. NATURE
- RNA-guided DNA insertion with CRISPR-associated transposases
- (2019) Jonathan Strecker et al. SCIENCE
- Orthotopic replacement of T-cell receptor α- and β-chains with preservation of near-physiological T-cell function
- (2019) Kilian Schober et al. Nature Biomedical Engineering
- Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR
- (2019) Sara Ghorashian et al. NATURE MEDICINE
- Clinical lessons learned from the first leg of the CAR T cell journey
- (2019) Robbie G. Majzner et al. NATURE MEDICINE
- Toxicity and Response following CD19-specific CAR T cells in pediatric/young adult relapsed/refractory B-ALL
- (2019) Kevin J. Curran et al. BLOOD
- Preclinical Characterization of Prgn-3006 Ultracar-T™ for the Treatment of AML and MDS: Non-Viral, Multigenic Autologous CAR-T Cells Administered One Day after Gene Transfer
- (2019) Tim Chan et al. BLOOD
- Shortened ex vivo manufacturing time of EGFRvIII-specific chimeric antigen receptor (CAR) T cells reduces immune exhaustion and enhances antiglioma therapeutic function
- (2019) Hillary G. Caruso et al. JOURNAL OF NEURO-ONCOLOGY
- A highly soluble Sleeping Beauty transposase improves control of gene insertion
- (2019) Irma Querques et al. NATURE BIOTECHNOLOGY
- Polymer-stabilized Cas9 nanoparticles and modified repair templates increase genome editing efficiency
- (2019) David N. Nguyen et al. NATURE BIOTECHNOLOGY
- A new approach to CAR T-cell gene engineering and cultivation using piggyBac transposon in the presence of IL-4, IL-7 and IL-21
- (2018) Pavlína Ptáčková et al. CYTOTHERAPY
- The siRNA-mediated downregulation of PD-1 alone or simultaneously with CTLA-4 shows enhanced in vitro CAR-T-cell functionality for further clinical development towards the potential use in immunotherapy of melanoma
- (2018) Bianca Simon et al. EXPERIMENTAL DERMATOLOGY
- Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia
- (2018) Chiara F. Magnani et al. HUMAN GENE THERAPY
- T Cells Genetically Modified to Express an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma
- (2018) Jennifer N. Brudno et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical use of lentiviral vectors
- (2018) Michael C. Milone et al. LEUKEMIA
- PiggyBac-Engineered T Cells Expressing CD19-Specific CARs that Lack IgG1 Fc Spacers Have Potent Activity against B-ALL Xenografts
- (2018) David C. Bishop et al. MOLECULAR THERAPY
- Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
- (2018) Jae H. Park et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhanced Expression of Anti-CD19 Chimeric Antigen Receptor in piggyBac Transposon-Engineered T Cells
- (2018) Daisuke Morita et al. Molecular Therapy-Methods & Clinical Development
- Reprogramming human T cell function and specificity with non-viral genome targeting
- (2018) Theodore L. Roth et al. NATURE
- Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells
- (2018) Joseph A. Fraietta et al. NATURE
- Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- (2018) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- New insights into the evolutionary origins of the recombination-activating gene proteins and V(D)J recombination
- (2017) Lina Marcela Carmona et al. FEBS Journal
- Wide Awake and Ready to Move: 20 Years of Non-Viral Therapeutic Genome Engineering with the Sleeping Beauty Transposon System
- (2017) Russ Hodge et al. HUMAN GENE THERAPY
- PGBD5 promotes site-specific oncogenic mutations in human tumors
- (2017) Anton G Henssen et al. NATURE GENETICS
- CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
- (2017) Terry J Fry et al. NATURE MEDICINE
- In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers
- (2017) Tyrel T. Smith et al. Nature Nanotechnology
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gene Therapy with the Sleeping Beauty Transposon System
- (2017) Partow Kebriaei et al. TRENDS IN GENETICS
- HIV-1-mediated insertional activation of STAT5B and BACH2 trigger viral reservoir in T regulatory cells
- (2017) Daniela Cesana et al. Nature Communications
- Sleeping Beauty transposition: from biology to applications
- (2016) Suneel A. Narayanavari et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients
- (2016) Cameron J. Turtle et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells
- (2016) Partow Kebriaei et al. JOURNAL OF CLINICAL INVESTIGATION
- Enhanced CAR T-cell engineering using non-viral Sleeping Beauty transposition from minicircle vectors
- (2016) R Monjezi et al. LEUKEMIA
- Endogenous Transposase Source in Human Cells Mobilizes piggyBac Transposons
- (2016) Zoltán Ivics MOLECULAR THERAPY
- Genome-wide Profiling Reveals Remarkable Parallels Between Insertion Site Selection Properties of the MLV Retrovirus and the piggyBac Transposon in Primary Human CD4+ T Cells
- (2016) Andreas Gogol-Döring et al. MOLECULAR THERAPY
- Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8 + and CD4 + CD19-specific chimeric antigen receptor–modified T cells
- (2016) Cameron J. Turtle et al. Science Translational Medicine
- Sleeping Beauty transposase structure allows rational design of hyperactive variants for genetic engineering
- (2016) Franka Voigt et al. Nature Communications
- Immunotherapy of acute leukemia by chimeric antigen receptor-modified lymphocytes using an improved Sleeping Beauty transposon platform
- (2016) Chiara F. Magnani et al. Oncotarget
- A High-Capacity Adenoviral Hybrid Vector System Utilizing the Hyperactive Sleeping Beauty Transposase SB100X for Enhanced Integration
- (2016) Philip Boehme et al. Molecular Therapy-Nucleic Acids
- The Sleeping Beauty Transposon Vector System for Treatment of Rare Genetic Diseases: An Unrealized Hope?
- (2015) Philip Boehme et al. CURRENT GENE THERAPY
- Low-cost generation of Good Manufacturing Practice–grade CD19-specific chimeric antigen receptor–expressing T cells using piggyBac gene transfer and patient-derived materials
- (2015) Saumya Ramanayake et al. CYTOTHERAPY
- A Hybrid Adenoviral Vector System Achieves Efficient Long-Term Gene Expression in the Liver viapiggyBacTransposition
- (2015) Ryan P. Smith et al. HUMAN GENE THERAPY
- Highly efficient homology-driven genome editing in human T cells by combining zinc-finger nuclease mRNA and AAV6 donor delivery
- (2015) Jianbin Wang et al. NUCLEIC ACIDS RESEARCH
- Genomic DNA transposition induced by human PGBD5
- (2015) Anton G Henssen et al. eLife
- Adoptive Immunotherapy Strategies with Cytokine-Induced Killer (CIK) Cells in the Treatment of Hematological Malignancies
- (2014) Frederic Schmeel et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cell-based strategies to manage leukemia relapse: efficacy and feasibility of immunotherapy approaches
- (2014) A Rambaldi et al. LEUKEMIA
- Chromatin Landscapes of Retroviral and Transposon Integration Profiles
- (2014) Johann de Jong et al. PLoS Genetics
- Optimization of the piggyBac Transposon Using mRNA and Insulators: Toward a More Reliable Gene Delivery System
- (2013) Solenne Bire et al. PLoS One
- piggyBac transposase tools for genome engineering
- (2013) X. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies
- (2013) G. L. Beatty et al. Cancer Immunology Research
- T Cells Expressing Chimeric Antigen Receptors Can Cause Anaphylaxis in Humans
- (2013) M. V. Maus et al. Cancer Immunology Research
- Efficient Sleeping Beauty DNA Transposition From DNA Minicircles
- (2013) Nynne Sharma et al. Molecular Therapy-Nucleic Acids
- Efficacy and Safety of Sleeping Beauty Transposon-Mediated Gene Transfer in Preclinical Animal Studies
- (2012) Perry B. Hackett et al. CURRENT GENE THERAPY
- Transposon mediated BAC transgenesis via pronuclear injection of mouse zygotes
- (2012) Maria Rostovskaya et al. GENESIS
- Transposon-mediated BAC transgenesis in human ES cells
- (2012) Maria Rostovskaya et al. NUCLEIC ACIDS RESEARCH
- The hyperactive Sleeping Beauty transposase SB100X improves the genetic modification of T cells to express a chimeric antigen receptor
- (2011) Z Jin et al. GENE THERAPY
- Nonviral Gene Delivery with the Sleeping Beauty Transposon System
- (2011) Zoltán Ivics et al. HUMAN GENE THERAPY
- Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery
- (2011) Melanie Galla et al. NUCLEIC ACIDS RESEARCH
- A hyperactive piggyBac transposase for mammalian applications
- (2011) K. Yusa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Determinants of intracellular RNA pharmacokinetics: Implications for RNA-based immunotherapeutics
- (2011) Andreas N. Kuhn et al. RNA Biology
- The expanding universe of transposon technologies for gene and cell engineering
- (2011) Zoltán Ivics et al. Mobile DNA
- Translating Sleeping Beauty transposition into cellular therapies: Victories and challenges
- (2010) Zsuzsanna Izsvák et al. BIOESSAYS
- Immune responses to transgene and retroviral vector in patients treated with ex vivo-engineered T cells
- (2010) C. H. J. Lamers et al. BLOOD
- Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor
- (2010) Y. Zhao et al. CANCER RESEARCH
- Gene Transfer Efficiency and Genome-Wide Integration Profiling of Sleeping Beauty, Tol2, and PiggyBac Transposons in Human Primary T Cells
- (2010) Xin Huang et al. MOLECULAR THERAPY
- A Transposon and Transposase System for Human Application
- (2010) Perry B Hackett et al. MOLECULAR THERAPY
- Emerging potential of transposons for gene therapy and generation of induced pluripotent stem cells
- (2009) T. VandenDriessche et al. BLOOD
- Chromosomal mobilization and reintegration ofSleeping BeautyandPiggyBactransposons
- (2009) Qi Liang et al. GENESIS
- Optimization of the PiggyBac Transposon System for the Sustained Genetic Modification of Human T Lymphocytes
- (2009) Yozo Nakazawa et al. JOURNAL OF IMMUNOTHERAPY
- Analysis of Lentiviral Vector Integration in HIV+ Study Subjects Receiving Autologous Infusions of Gene Modified CD4+ T Cells
- (2009) Gary P Wang et al. MOLECULAR THERAPY
- Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates
- (2009) Lajos Mátés et al. NATURE GENETICS
- Transposon-mediated genome manipulation in vertebrates
- (2009) Zoltán Ivics et al. NATURE METHODS
- Ectopic expression of a truncated CD40L protein from synthetic post-transcriptionally capped RNA in dendritic cells induces high levels of IL-12 secretion
- (2008) Irina Y Tcherepanova et al. BMC MOLECULAR BIOLOGY
- Redirecting Specificity of T-Cell Populations For CD19 Using the Sleeping Beauty System
- (2008) H. Singh et al. CANCER RESEARCH
- Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
- (2008) Salima Hacein-Bey-Abina et al. JOURNAL OF CLINICAL INVESTIGATION
- Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
- (2008) Katalin Karikó et al. MOLECULAR THERAPY
- Multiplex RT-PCR Amplification of HIV Genes to Create a Completely Autologous DC-Based Immunotherapy for the Treatment of HIV Infection
- (2008) Irina Tcherepanova et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started